Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials (vol 4, pg e53, 2022)

被引：0
|
作者：
Stamp, L. K.
Frampton, C.
Morillon, M. B.
机构：
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E530 / E530
页数：1
相关论文
共 7 条
  • [1] Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials
    Stamp, Lisa K.
    Frampton, Christopher
    Morillon, Melanie B.
    Taylor, William J.
    Dalbeth, Nicola
    Singh, Jasvinder A.
    Doherty, Michael
    Zhang, Weiya
    Richardson, Helen
    Sarmanova, Aye
    Christensen, Robin
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E53 - E60
  • [2] Association between Serum Urate As a Surrogate Endpoint and Flares in People with Gout: An Ecological Study Based on a Systematic Review of Trials and Open Label Extensions
    Stamp, Lisa K.
    Morillon, Melanie
    Taylor, William
    Dalbeth, Nicola
    Lassere, Marissa
    Singh, Jasvinder A.
    Christensen, Robin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis (vol 48, pg 293, 2018)
    Stamp, Lisa K.
    Morillon, Melanie B.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [4] Serum Urate Reduction Is Causally Associated with Flare Outcomes in People with Gout: Evidence for Surrogate Status from a Pooled Analysis of 2 Randomized Trials
    Stamp, Lisa
    Frampton, Chris
    Morillon, Melanie
    Taylor, William
    Dalbeth, Nicola
    Singh, Jasvinder
    Doherty, Micheal
    Zhang, Weiya
    Richardson, Helen
    Sarmanova, Aliya
    Christensen, Robin
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1350 - 1351
  • [5] THE ASSOCIATION BETWEEN COMORBIDITY AND PHYSICAL ACTIVITY LEVELS IN PEOPLE WITH OSTEOARTHRITIS: SECONDARY ANALYSIS FROM TWO RANDOMISED CONTROLLED TRIALS
    Mckevitt, S.
    Healey, E. L.
    Jinks, C.
    Rathod-Mistry, T.
    Quicke, J. G.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S494 - S494
  • [6] Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study (vol 4, pg e262, 2022)
    Coates, L. C.
    Tillett, W.
    D'Agostino, M-A
    LANCET RHEUMATOLOGY, 2022, 4 (04): : E249 - E249
  • [7] Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study (vol 4, pg e262, 2022)
    Coates, L. C.
    Tillett, W.
    D'Agostino, M-A
    LANCET RHEUMATOLOGY, 2022, 4 (06): : E392 - E392
1